Skip to main content

Animations

MJFF Publications

121 - 130 of 9034 Results
Title
Year
  • Year
  • 2022
  • 2016
  • 2023
  • 2023
  • 2012
  • 2020
  • 2023
  • 2023
  • 2017
  • 2016
  • Summary Details
    RESTRICTED
    Title: Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23116216
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.13390
    Citation Count: 58
  • Summary Details
    RESTRICTED
    Title: Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13482
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Artificial intelligence for neurodegenerative experimental models
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13479
    Citation Count: 3
  • Recent advances in CSF biomarkers for Parkinson's disease
    2012
    Summary Details
    RESTRICTED
    Title: Recent advances in CSF biomarkers for Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1353-8020(11)70017-7
    Citation Count: 26
  • Summary Details
    RESTRICTED
    Title: Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104619
    Citation Count: 57
  • Summary Details
    RESTRICTED
    Title: Association of Rare Variants in ARSA with Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29521
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Pick’s Disease, Seeding an Answer to the Clinical Diagnosis Conundrum
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines11061646
    Citation Count: 3
  • Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
    2017
    Summary Details
    RESTRICTED
    Title: Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.10.001
    Citation Count: 50
  • Injury to the nervous system: A look into the ER
    2016
    Summary Details
    RESTRICTED
    Title: Injury to the nervous system: A look into the ER
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.053
    Citation Count: 24
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.